Try our Advanced Search for more refined results
August 30, 2013
Gilead Sciences, Inc. v. Merck & Co, Inc. et al
Case Number:
3:13-cv-04057
See also:
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 03, 2013
Gilead Says New Hepatitis Drug Does Not Infringe Merck IP
Gilead Sciences Inc. has asked a federal court in California to issue a declaratory judgment that its hepatitis C drug would not infringe two Merck & Co. Inc. patents, or to deem the patents invalid, according to a suit filed Friday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login